The current study shows that in a model of CRC, the effects of the KITENIN/ErbB4 oncogenic complex, which in previous reports were shown to modulate cell motility and aerobic glycolysis, are suppressed by chrysophanol, a compound that cleaves the KITENIN/ErbB4 complex. This evidence concerns the gene ERBB4 and colorectal carcinoma.